Drug Trial Radar · NCT06468202
Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL
Last checked: Nov 20, 2026Latest source record: Oct 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
10,742
Planned (sponsor's estimate)
Start
Oct 18, 2024
Primary completion
Jan 1, 2029
Study completion Feb 1, 2030
Sponsor
- Lead sponsor
- Ohio State UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Patient-Centered Outcomes Research Institute; Northwestern University; Preeclampsia Foundation
- First posted
- Jun 21, 2024
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 14 years, up to 35 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The overall goal of this large, pragmatic, comparative effectiveness trial is to test the hypothesis that among at-risk individuals, 162 mg/day aspirin is superior to 81 mg/day in preventing Hypertensive disorders of pregnancy (HDP), and that there are multiple factors associated with adherence with aspirin therapy that will be important to identify to enable optimal implementation of study findings and population-level benefits.
Conditions
- Hypertensive Disorders of Pregnancy
- Preeclampsia
- Gestational Hypertension
Interventions
Aspirin 81 mgDrug
Participants will be assigned to 81mg Aspirin
Aspirin 162 mgDrug
Participants will be assigned to 162mg Aspirin
Primary outcomes
What the sponsor says the trial is designed to measure.
- Hypertensive Disorder of Pregnancy (HDP)Time frame: From >20 weeks gestation until hospital discharge following delivery, up to 22 weeks
Locations
20 sites in 1 country. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama · Recruiting
Cedars Sinai Medical Center
Los Angeles, California · Recruiting
University of California, San Francisco
San Francisco, California · Recruiting
Northwestern University
Chicago, Illinois · Recruiting
Ochsner Baptist Medical Center
New Orleans, Louisiana · Not yet recruiting
University of Mississippi
Jackson, Mississippi · Active not recruiting
University of New Mexico
Albuquerque, New Mexico · Recruiting
Columbia University
New York, New York · Recruiting
University of North Carolina, Chapel Hill
Chapel Hill, North Carolina · Recruiting
The Ohio State University Wexner Medical Center OB/GYN Maternal and Fetal Medicine
Columbus, Ohio · Recruiting
University of Pittsburg Magee
Pittsburgh, Pennsylvania · Recruiting
Brown University
Providence, Rhode Island · Recruiting
University of South Carolina Greenville
Greenville, South Carolina · Not yet recruiting
Austin Maternal Fetal Medicine
Austin, Texas · Not yet recruiting
Baylor College of Medicine
Houston, Texas · Not yet recruiting
University of Texas, Houston
Houston, Texas · Recruiting
University of Utah
Salt Lake City, Utah · Recruiting
Inova HealthSystem
Falls Church, Virginia · Recruiting
Eastern Virginia Medical School - Old Dominion University
Norfolk, Virginia · Recruiting
Medical College of Wisconsin
Milwaukee, Wisconsin · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.